glp-1 alzheimer's disease Role of glucagon-like peptide-1 receptor agonists in and Parkinson's disease | Journal of Biomedical Science GLP-1 drugs failed to slow

Learn the VA's coverage rules, eligibility criteria, and how to access GLP-1 medications like Ozempic through veteran benefits.

Statin medications may lower your cholesterol but the cost to you may be increased risk of dementia, worsening of your diabetes and increased weight gain.

The use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and obesity, may be associated with a wide range of health effects, both positive - such as a reduced risk of cardiometabolic disorders - and negative - an increased risk of gastrointestinal conditions or hypertension

The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began